<DOC>
	<DOCNO>NCT00039624</DOCNO>
	<brief_summary>This study evaluate use magnetic resonance imaging ( MRI ) guide placement hollow needle prostate gland deliver internal radiation therapy patient prostate cancer . Prostate cancer often treat combination external beam radiation therapy brachytherapy ( internal radiation deliver close tumor ) . This study determine whether MRI accurate guide needle placement ultrasound , currently use purpose . Patients one brachytherapy treatment follow 5 week external beam treatment second brachytherapy . Patients 18 year age old prostate cancer spread bone may eligible study . Candidates screen physical examination , blood urine test , bone scan . To plan radiation therapy , patient standard compute tomography ( CT ) MRI scan pelvis prostate . In addition , CT MRI scan do determine prostate good position brachytherapy . For scan , patient enema tube place rectum . They lie still side 45 minute scan . Patients blood urine also undergo cystoscopy . This examination bladder use small camera advance penis bladder . Patients give antibiotic 2 day brachytherapy morning procedure . Before test , small enema give medicine vein spine relaxation decrease discomfort . ( The test do general anesthesia patient require . ) The patient move stretcher MRI scanner catheter insert bladder penis . The bladder fill water tube place rectum . With help plastic guide place skin , 14 18 needle place prostate . Some stitch sew hold needle guide place , tube rectum remove . The patient transfer MR scanner CT scanner , rectal tube reinserted needle adjust . A cystoscopy do make sure needle enter bladder . When needle adjust , tube remove rectum patient move radiation oncology clinic . After hour , radiation dose calculate , radioactive substance call iridium administer . The needle place prostate connect radiation machine , thin wire radioactive material tip insert needle withdrawn little time . The process take 20 30 minute . The patient disconnect machine undergoes another MRI scan confirm position needle . The needle catheter remove patient monitor go home . Patients 5 week external beam therapy , follow second brachytherapy treatment . Patients return clinic 1 , 3 , 6 , 12 , 18 , 24 , 36 , 48 , 60 month treatment blood test , physical examination , review symptom .</brief_summary>
	<brief_title>Magnetic Resonance-Guided High-Dose Brachytherapy ( Short-Range Radiation Therapy ) Prostate Cancer</brief_title>
	<detailed_description>BACKGROUND Brachytherapy , placement radioactive source close tumor , rapidly become important modality patient prostate cancer high conformal dos safely deliver compare external beam radiotherapy . High dose rate ( HDR ) temporary implant offer several treatment research base advantage permanent seed , include exceptionally complex accurate dosimetry reference anatomic image . Needle placement brachytherapy procedure require detailed image guidance , traditionally obtain trans-rectal ultrasound ( TRUS ) . MRI offer 3D dataset , arbitrary imaging plane , unparalleled soft tissue resolution anatomy , make modality choice image prostate gland . A real-time MR-guided prostate permanent seed implant technique utilizes real-time MRI real-time dosimetry design , implement report . Results confirm TRUS-guided implant may improve upon use MRI . To knowledge , HDR implant yet perform MR guidance close bore magnet . OBJECTIVES The primary objective determine quality prostate HDR brachytherapy implant perform MR-guidance . Quality define percentage planning target volume ( PTV ) encompass give percentage prescribe dose . In study implant `` acceptable '' quality 80 % PTV encompass 100 % isodose ( V100 80 % ) , accordance RTOG guideline . ELIGIBILITY Pathologically confirm prostate cancer follow feature : - Gleason score great 6 , great T2a , - PSA great equal 10 , evidence bone metastasis ; Age great equal 18 year ; ECOG performance status 0 1 DESIGN The study design `` run-in '' pilot phase objective refining technique . The evaluation phase two-stage optimal design evaluate quality implant early look futility . This study potential enroll maximum 27 patient . Radiation treatment parameter pattern establish guideline literature report American Brachytherapy Society William-Beaumont Hospital . There attempt dose escalation attempt prescribe dose unconventional target volume phase project .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>INCLUSION CRITERIA : Pathologically confirm prostate cancer follow feature : Gleason score great 6 , great T2a , PSA great equal 10 , evidence bone metastases Age great equal 18 year ECOG performance status 0 1 Informed consent : All patient must sign document inform consent indicate understanding investigational nature risk study protocol relate study perform ( include routine laboratory test image study require establish eligibility ) . EXCLUSION CRITERIA : History prior pelvic prostate radiotherapy TURP within last 6 month large TURP defect Contraindication implant procedure : Bleeding disorder Active anticoagulation time implant Artificial heart valve Contraindication MRI : Patients weigh great 136 kg ( weight limit scanner table ) Patients pacemaker , cerebral aneurysm clip , shrapnel injury implantable electronic device . Preexisting significant urinary obstructive symptom reflect high ( great 18 ) International Prostate Symptom Score ( IPSS ) Pubic arch interference inadequate access perineum determine preliminary MRI Cognitively impair patient give informed consent Medically Unfit Anesthesia define anesthesiology consultant Other active malignancy ( except nonmelanoma skin cancer malignancy treat curative intent least 3 year ago evidence recurrent disease . ) Other urinary medical condition deem PI associate make patient ineligible high dose rate brachytherapy EBRT .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>October 11, 2016</verification_date>
	<keyword>Radiation Therapy</keyword>
	<keyword>Prostate</keyword>
	<keyword>MRI</keyword>
	<keyword>Brachytherapy</keyword>
	<keyword>Phase II</keyword>
	<keyword>Prostate Cancer</keyword>
</DOC>